<unk>  is experienced by 53 percent of all people diagnosed with malignant<unk> , 59 percent of people receiving anticancer treatment, 64 percent of people with metastatic or advanced-stage disease, and 33 percent of people after completion of curative treatment. Evidence for prevalence of<unk>  in newly diagnosed<unk>  is scarce. One study found<unk>  in 38 percent of people who were newly diagnosed, another found 35 percent of such people had experienced<unk>  in the preceding two weeks, while another reported that<unk>  was an early symptom in 18–49 percent of cases. More than one third of people with<unk>  describe the<unk>  as moderate or severe. Primary tumors in the following locations are associated with a relatively high prevalence of<unk> : * Head and neck (67 to 91 percent) * Prostate (56 to 94 percent) * Uterus (30 to 90 percent) * The genitourinary system (58 to 90 percent) * Breast (40 to 89 percent) * Pancreas (72 to 85 percent) * Esophagus (56 to 94 percent) All people with advanced multiple myeloma or advanced sarcoma are likely to experience<unk> .
Cancer pain
Chronic pain
Cancer signs and symptoms
Cancer syndrome
Chronic wound pain
Psychogenic pain
Visceral pain
Stroke recovery